129 related articles for article (PubMed ID: 35764103)
1. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Rush RB; Velazquez JC; Rosales CR; Rush SW
Am J Ophthalmol; 2022 Oct; 242():173-180. PubMed ID: 35764103
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
3. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
4. SILICONE OIL VERSUS PERFLUOROPROPANE GAS TAMPONADE DURING VITRECTOMY FOR TRACTIONAL RETINAL DETACHMENT OR FIBROUS PROLIFERATION: A Randomized Clinical Trial.
Rush RB; Del Valle Penella A; Reinauer RM; Rush SW; Bastar PG
Retina; 2021 Jul; 41(7):1407-1415. PubMed ID: 33252584
[TBL] [Abstract][Full Text] [Related]
5. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
7. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
[TBL] [Abstract][Full Text] [Related]
9. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
Aleman I; Castillo Velazquez J; Rush SW; Rush RB
Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
[TBL] [Abstract][Full Text] [Related]
10. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
11. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage.
Koutsandrea CN; Apostolopoulos MN; Chatzoulis DZ; Parikakis EA; Theodossiadis GP
Acta Ophthalmol Scand; 2001 Feb; 79(1):34-8. PubMed ID: 11167284
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
14. INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC VITREOUS HEMORRHAGE: A Randomized Clinical Trial.
Rush RB; Del Valle Penella A; Reinauer RM; Rush SW; Bastar PG
Retina; 2021 May; 41(5):1118-1126. PubMed ID: 32910084
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial.
Jorge DM; Tavares Neto JEDS; Poli-Neto OB; Scott IU; Jorge R
Int J Retina Vitreous; 2021 Apr; 7(1):35. PubMed ID: 33902755
[TBL] [Abstract][Full Text] [Related]
16. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
17. Intraocular Fibrin Glue to Lower the Risk of Postoperative Vitreous Hemorrhage After Diabetic Pars Plana Vitrectomy.
Mansour HA; Mahmoudzadeh R; Hsu J
Retina; 2023 Dec; 43(12):2148-2152. PubMed ID: 36731110
[TBL] [Abstract][Full Text] [Related]
18. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
Göncü T; Özdek S; Ünlü M
Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
[TBL] [Abstract][Full Text] [Related]
19. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].
Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF
Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
